Therefore, abnormal activation of the PI3K/AKT/Hmox1 pathway may play a critical role in the development of liver fibrosis, suggesting that it could serve as a novel therapeutic intervention target. The gene discussed is AKT1; the disease is Hepatic fibrosis.